AU2019277405A1
|
|
Non-destructive sampling system and method for quality assessment of blood products, and sampling systems therefor
|
EP3241904A1
|
|
Factor xia-specific aptamers
|
CA2998909A1
|
|
Monovalent chimeras
|
WO2016004538A1
|
|
Combination therapy of a cellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system
|
EP2813567A1
|
|
C-terminally tethered amino acids and their fibrinolytic therapeutic uses
|
WO2014138979A1
|
|
Pyrazole derivatives and their uses thereof
|
CA2917567A1
|
|
Acellular pro-inflammatory compositions, process for making same and methods of using same
|
WO2015003240A1
|
|
Acellular pro-inflammatory compositions, process for making same and methods of using same
|
US2014329319A1
|
|
Apparatus and method for the immunocamouflage of biological cells
|
CA2782942A1
|
|
Method for inducing immune tolerance using polymer-modified antigenic leukocytes
|
EP2612127A1
|
|
Container for non-invasive fluid sample access
|
WO2012030636A1
|
|
Sample holder for dynamic light scattering
|
EP2488853A1
|
|
Dual analyzer system for biological fluid
|
CA2686135A1
|
|
Chimeric hirudin proteins
|
CA2689726A1
|
|
Antibodies against gpi.alpha.
|
CA2639003A1
|
|
Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations
|
EP2163261A1
|
|
Cold storage of PEG modified platelets
|
CA2637517A1
|
|
Cold storage of modified platelets
|
CA2728833A1
|
|
Dynamic light scattering for in vitro testing of bodily fluids
|
EP2025685A1
|
|
Monoclonal antibodies against BETA3 integrins
|